Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Differential Phosphorylation, Desensitization, and Internalization of α1A−Adrenoceptors Activated by Norepinephrine and Oxymetazoline

Juliana Akinaga, Vanessa Lima, Luiz Ricardo de Almeida Kiguti, Flávia Hebeler-Barbosa, Rocío Alcántara-Hernández, J. Adolfo García-Sáinz and André Sampaio Pupo
Molecular Pharmacology April 2013, 83 (4) 870-881; DOI: https://doi.org/10.1124/mol.112.082313
Juliana Akinaga
Department of Pharmacology, Instituto de Biociências, Universidade Estadual Paulista (UNESP), Botucatu, São Paulo, Brazil (J.A., V.L., L.R.A.K., F.H.-B., A.S.P.); and Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico (R.A.-H. and J.A.G.-S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vanessa Lima
Department of Pharmacology, Instituto de Biociências, Universidade Estadual Paulista (UNESP), Botucatu, São Paulo, Brazil (J.A., V.L., L.R.A.K., F.H.-B., A.S.P.); and Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico (R.A.-H. and J.A.G.-S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luiz Ricardo de Almeida Kiguti
Department of Pharmacology, Instituto de Biociências, Universidade Estadual Paulista (UNESP), Botucatu, São Paulo, Brazil (J.A., V.L., L.R.A.K., F.H.-B., A.S.P.); and Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico (R.A.-H. and J.A.G.-S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Flávia Hebeler-Barbosa
Department of Pharmacology, Instituto de Biociências, Universidade Estadual Paulista (UNESP), Botucatu, São Paulo, Brazil (J.A., V.L., L.R.A.K., F.H.-B., A.S.P.); and Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico (R.A.-H. and J.A.G.-S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rocío Alcántara-Hernández
Department of Pharmacology, Instituto de Biociências, Universidade Estadual Paulista (UNESP), Botucatu, São Paulo, Brazil (J.A., V.L., L.R.A.K., F.H.-B., A.S.P.); and Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico (R.A.-H. and J.A.G.-S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Adolfo García-Sáinz
Department of Pharmacology, Instituto de Biociências, Universidade Estadual Paulista (UNESP), Botucatu, São Paulo, Brazil (J.A., V.L., L.R.A.K., F.H.-B., A.S.P.); and Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico (R.A.-H. and J.A.G.-S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
André Sampaio Pupo
Department of Pharmacology, Instituto de Biociências, Universidade Estadual Paulista (UNESP), Botucatu, São Paulo, Brazil (J.A., V.L., L.R.A.K., F.H.-B., A.S.P.); and Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico (R.A.-H. and J.A.G.-S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Loss of response on repetitive drug exposure (i.e., tachyphylaxis) is a particular problem for the vasoconstrictor effects of medications containing oxymetazoline (OXY), an α1-adrenoceptor (AR) agonist of the imidazoline class. One cause of tachyphylaxis is receptor desensitization, usually accompanied by phosphorylation and internalization. It is well established that α1A-ARs are less phosphorylated, desensitized, and internalized on exposure to the phenethylamines norepinephrine (NE), epinephrine, or phenylephrine (PE) than are the α1B and α1D subtypes. However, here we show in human embryonic kidney-293 cells that the low-efficacy agonist OXY induces G protein–coupled receptor kinase 2–dependent α1A-AR phosphorylation, followed by rapid desensitization and internalization (∼40% internalization after 5 minutes of stimulation), whereas phosphorylation of α1A-ARs exposed to NE depends to a large extent on protein kinase C activity and is not followed by desensitization, and the receptors undergo delayed internalization (∼35% after 60 minutes of stimulation). Native α1A-ARs from rat tail artery and vas deferens are also desensitized by OXY, but not by NE or PE, indicating that this property of OXY is not limited to recombinant receptors expressed in cell systems. The results of the present study are clearly indicative of agonist-directed α1A-AR regulation. OXY shows functional selectivity relative to NE and PE at α1A-ARs, leading to significant receptor desensitization and internalization, which is important in view of the therapeutic vasoconstrictor effects of this drug and the varied biologic process regulated by α1A-ARs.

Footnotes

  • This work was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) [Grant 08/50423-7], Coordenação de Aperfeiçoamento de Pessoal de Nível Superior CAPES [Grant 9150/11-0], Dirección General de Asuntos de Personal Académico-Universidad Nacional Autónoma de México DGAPA-UNAM [Grant IN200812], and Consejo Nacional de Ciencia y Tecnología CONACYT [Grant 177556].

  • dx.doi.org/10.1124/mol.112.082313.

  • Received September 10, 2012.
  • Accepted January 30, 2013.
  • Copyright © 2013 by The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 83 (4)
Molecular Pharmacology
Vol. 83, Issue 4
1 Apr 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Differential Phosphorylation, Desensitization, and Internalization of α1A−Adrenoceptors Activated by Norepinephrine and Oxymetazoline
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

α1A-Adrenoceptor Regulation by Oxymetazoline

Juliana Akinaga, Vanessa Lima, Luiz Ricardo de Almeida Kiguti, Flávia Hebeler-Barbosa, Rocío Alcántara-Hernández, J. Adolfo García-Sáinz and André Sampaio Pupo
Molecular Pharmacology April 1, 2013, 83 (4) 870-881; DOI: https://doi.org/10.1124/mol.112.082313

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

α1A-Adrenoceptor Regulation by Oxymetazoline

Juliana Akinaga, Vanessa Lima, Luiz Ricardo de Almeida Kiguti, Flávia Hebeler-Barbosa, Rocío Alcántara-Hernández, J. Adolfo García-Sáinz and André Sampaio Pupo
Molecular Pharmacology April 1, 2013, 83 (4) 870-881; DOI: https://doi.org/10.1124/mol.112.082313
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
  • Benzbromarone relaxes airway smooth muscle via BK activation
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics